右美托咪定：重症监护病房抗击新冠疫情的又一利器。 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

右美托咪定：重症监护病房抗击新冠疫情的又一利器。 - Suppr | 超能文献

Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.

作者信息

Jain Amit, Lamperti Massimo, Doyle D John

机构信息

Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Anesthesiology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

出版信息

Br J Anaesth. 2021 Jan;126(1):e35-e38. doi: 10.1016/j.bja.2020.10.010. Epub 2020 Oct 14.

DOI:10.1016/j.bja.2020.10.010

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7556802/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/7556802/efb6123fca8c/gr1_lrg.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/7556802/efb6123fca8c/gr1_lrg.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16dd/7556802/efb6123fca8c/gr1_lrg.jpg

相似文献

1

Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.右美托咪定：重症监护病房抗击新冠疫情的又一利器。

Br J Anaesth. 2021 Jan;126(1):e35-e38. doi: 10.1016/j.bja.2020.10.010. Epub 2020 Oct 14.

2

Dexmedetomidine in COVID-19: probing promises with prudence!右美托咪定用于新型冠状病毒肺炎：谨慎探索前景！

Am J Emerg Med. 2021 Aug;46:708-709. doi: 10.1016/j.ajem.2020.10.034. Epub 2020 Oct 27.

3

[A comparative study on clinical effects of dexmedetomidine and midazolam on patients with severe coronavirus disease 2019 on non-invasive ventilation].右美托咪定与咪达唑仑对新型冠状病毒肺炎重型患者无创通气临床效果的对比研究

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jun;32(6):677-680. doi: 10.3760/cma.j.cn121430-20200305-00187.

4

Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.重症监护中右美托咪定与丙泊酚或咪达唑仑标准护理镇静的经济学评价

Crit Care. 2015 Feb 19;19(1):67. doi: 10.1186/s13054-015-0787-y.

5

Dexmedetomidine (Precedex) for ICU sedation.用于重症监护病房镇静的右美托咪定（普瑞博思）。

Med Lett Drugs Ther. 2011 May 30;53(1365):41-2.

6

Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review.用于重症监护病房中机械通气成人镇静的α-2激动剂：一项系统评价

Health Technol Assess. 2016 Mar;20(25):v-xx, 1-117. doi: 10.3310/hta20250.

7

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine.重症监护病房中的镇静与镇痛：评估右美托咪定的作用

Am J Health Syst Pharm. 2007 Jan 1;64(1):37-44. doi: 10.2146/ajhp050508.

8

Dexmedetomidine, a revolution for sedation in ICU?右美托咪定，重症监护病房镇静的一场革命？

Anaesth Crit Care Pain Med. 2016 Feb;35(1):5-6. doi: 10.1016/j.accpm.2015.10.001. Epub 2015 Dec 9.

9

Con: Dexmedetomidine Sedation Should Not Be Used Routinely for All Post-cardiac Surgical Patients in the Intensive Care Unit.反对观点：在重症监护病房中，右美托咪定镇静不应常规用于所有心脏手术后患者。

J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1422-4. doi: 10.1053/j.jvca.2016.05.043. Epub 2016 May 30.

10

Pro: Dexmedetomidine Sedation Should Be Used Routinely for All Post-Cardiac Surgical Patients in the Intensive Care Unit.赞成：对于重症监护病房中所有心脏手术后的患者，应常规使用右美托咪定进行镇静。

J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1419-21. doi: 10.1053/j.jvca.2016.05.042. Epub 2016 May 30.

引用本文的文献

1

Dexmedetomidine improves clinical outcomes in sepsis-induced myocardial injury: a retrospective cohort study.右美托咪定改善脓毒症诱导的心肌损伤的临床结局：一项回顾性队列研究。

Front Pharmacol. 2025 Jan 15;15:1529167. doi: 10.3389/fphar.2024.1529167. eCollection 2024.

2

Association between Dexmedetomidine Use and Mortality in Patients with COVID-19 Receiving Invasive Mechanical Ventilation: A U.S. National COVID Cohort Collaborative (N3C) Study.右美托咪定使用与接受有创机械通气的COVID-19患者死亡率之间的关联：一项美国国家COVID队列协作研究（N3C）

J Clin Med. 2024 Jun 12;13(12):3429. doi: 10.3390/jcm13123429.

3

Combinations of nerve blocks in surgery for post COVID-19 pulmonary sequelae patient: A case report and review of literature.

本文引用的文献

1

Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU.右美托咪定对入住重症监护病房的COVID-19患者的潜在治疗价值。

Br J Anaesth. 2021 Jan;126(1):e33-e35. doi: 10.1016/j.bja.2020.09.031. Epub 2020 Oct 2.

2

A novel role for lidocaine in COVID-19 patients?利多卡因在新冠病毒肺炎患者中具有新作用？

Br J Anaesth. 2020 Oct;125(4):e391-e394. doi: 10.1016/j.bja.2020.07.015. Epub 2020 Jul 23.

3

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

新冠病毒感染后肺部后遗症患者手术中神经阻滞的联合应用：一例病例报告及文献综述

World J Clin Cases. 2023 Feb 16;11(5):1198-1205. doi: 10.12998/wjcc.v11.i5.1198.

4

The impact of stress and anesthesia on animal models of infectious disease.压力和麻醉对传染病动物模型的影响。

Front Vet Sci. 2023 Feb 2;10:1086003. doi: 10.3389/fvets.2023.1086003. eCollection 2023.

5

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons.新冠病毒疾病中的高迁移率族蛋白B1（HMGB1）：危险关联的推断

Inflammopharmacology. 2022 Jun;30(3):811-820. doi: 10.1007/s10787-022-00988-y. Epub 2022 Apr 26.

6

The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19.α-2肾上腺素能受体激动剂与COVID-19患者死亡率的关联

Front Med (Lausanne). 2022 Jan 4;8:797647. doi: 10.3389/fmed.2021.797647. eCollection 2021.

7

Post-operative Non-sustained Ventricular Tachycardia in a COVID-19 Positive Patient After Ketamine and Dexmedetomidine Infusion.一名新冠病毒检测呈阳性的患者在输注氯胺酮和右美托咪定后出现术后非持续性室性心动过速。

Cureus. 2021 Dec 9;13(12):e20300. doi: 10.7759/cureus.20300. eCollection 2021 Dec.

8

Anaesthesia drugs, SARS-CoV-2, and the sigma-1 receptor: a complex affair. Comment on Br J Anaesth 2021; 127: e32-4.麻醉药物、严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与σ-1受体：一个复杂的问题。对《英国麻醉学杂志》2021年；127卷：e32 - 4的评论

Br J Anaesth. 2021 Dec;127(6):e215-e218. doi: 10.1016/j.bja.2021.09.008. Epub 2021 Sep 20.

9

Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: A retrospective cohort study.地塞米松对危重症 COVID-19 患者的血流动力学和呼吸影响：一项回顾性队列研究。

Acta Anaesthesiol Scand. 2021 Nov;65(10):1447-1456. doi: 10.1111/aas.13970. Epub 2021 Aug 22.

10

Sedation in mechanically ventilated covid-19 patients: A narrative review for emergency medicine providers.机械通气的新冠-19患者的镇静：面向急诊医学从业者的叙述性综述

Am J Emerg Med. 2022 Apr;54:309-311. doi: 10.1016/j.ajem.2021.05.030. Epub 2021 May 14.

高血糖水平通过 HIF-1α/糖酵解依赖轴促进 SARS-CoV-2 感染和单核细胞反应。

Cell Metab. 2020 Sep 1;32(3):437-446.e5. doi: 10.1016/j.cmet.2020.07.007. Epub 2020 Jul 17.

4

Severe COVID-19: NLRP3 Inflammasome Dysregulated.严重 COVID-19：NLRP3 炎性小体失调。

Front Immunol. 2020 Jun 26;11:1580. doi: 10.3389/fimmu.2020.01580. eCollection 2020.

5

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.新冠病毒肺炎患者入院时血清中S100A8/A9和HMGB1水平升高与较差的临床结局相关。

Cell Mol Immunol. 2020 Sep;17(9):992-994. doi: 10.1038/s41423-020-0492-x. Epub 2020 Jul 3.

6

Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report.COVID-19 患者使用右美托咪定后出现缺氧恶化：病例报告。

Am J Emerg Med. 2020 Oct;38(10):2247.e1-2247.e2. doi: 10.1016/j.ajem.2020.05.066. Epub 2020 May 27.

7

COVID-19 and the nicotinic cholinergic system.新型冠状病毒肺炎与烟碱型胆碱能系统。

Eur Respir J. 2020 Jul 16;56(1). doi: 10.1183/13993003.01589-2020. Print 2020 Jul.

8

Dexmedetomidine inhibits LPS-induced proinflammatory responses via suppressing HIF1α-dependent glycolysis in macrophages.右美托咪定通过抑制巨噬细胞中 HIF1α 依赖性糖酵解来抑制 LPS 诱导的促炎反应。

Aging (Albany NY). 2020 May 20;12(10):9534-9548. doi: 10.18632/aging.103226.

9

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome.COVID-19：一种新病毒，但熟悉的受体和细胞因子释放综合征。

Immunity. 2020 May 19;52(5):731-733. doi: 10.1016/j.immuni.2020.04.003. Epub 2020 Apr 22.

10

Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.右美托咪定通过 SIRT1 下调介导的 FOXO3a 激活来防止利多卡因诱导的神经毒性。

Hum Exp Toxicol. 2020 Sep;39(9):1213-1223. doi: 10.1177/0960327120914971. Epub 2020 Mar 31.